St. Jude creates global data registry to monitor impact of COVID-19 on pediatric cancer

Memphis, Tenn.-based St. Jude Children’s Research Hospital partnered with the International Society of Paediatric Oncology to launch a global COVID-19 data registry and resource center for pediatric cancer.

Advertisement

The website hosts a pediatric cancer registry that collects and organizes de-identified data from pediatric cancer patients who have been diagnosed with COVID-19. Healthcare institutions across the world can submit data, and the registry provides real-time analytics of the information.

In addition to collecting COVID-19 data, the platform hosts online seminars and workshops for physicians to share their best practices for treating pediatric patients with both cancer and COVID-19.

“The registry is a high-level, first-pass effort to get the information quickly, because what we find out now can guide future interventions,” Kathy Pritchard-Jones, society president, said in a news release. “With the data generated by the registry, we will be able to create an observatory to monitor the impact of COVID-19 on childhood cancer care and control.”

More articles on data analytics:
How healthcare is using tech to accelerate COVID-19 contract tracing 
Wake Forest, Oracle collaborate on web portal to collect daily information on large populations 
How Atrium Health decides where to open COVID-19 testing cites

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.